Skip to content
Dose Brief
Menu

Medro Review — GLP-1 Access Unconfirmed

By Updated

Medro’s public website and GLP-1 page returned not-found responses. Current enrollment and prices are unconfirmed.

Historical Brief Score68/100Recorded grade CDirectory position by recorded score: 194
Compare current provider information See other options for weight care.
Semaglutide

Current price and access unconfirmed.

Tirzepatide

Current price and access unconfirmed.

Current availability
Current service area unconfirmed.
Prescription offer
Current prescription offer unconfirmed
AvailabilityPrescription availability unconfirmed— Earlier Medro prices do not establish a current offer.

Medro in depth

What can be verified now

The Medro homepage (opens in a new tab) and GLP-1 page (opens in a new tab) returned not-found responses. Earlier listings described independent clinical and pharmacy partners. Use the provider-selection guide to find services with current public enrollment terms. The website errors do not establish whether Medro has closed.

If you have an order

For an existing prescription, the pharmacy checklist explains how to identify the dispenser from your label or order confirmation. Check with the clinician or pharmacy named in your own records about a pending refill.

Earlier Medro pages discussed both orders without a default membership and separately selected recurring services. Use the cancellation checklist to see whether your own purchase authorized renewal and which company handles any refund.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

Historical score

Retained from the earlier program listing; this score does not rate current prescription availability. See the methodology.

Price Stability46/100
Supply Reliability73/100
Transparency68/100
Access Breadth96/100
Clinical Oversight71/100
Track Record64/100

What the sources establish

  • Earlier materials distinguished the platform from the clinical and pharmacy partners

What still needs checking

  • The public GLP-1 page did not load
  • Current payment and refund terms could not be verified

The brief

Useful for: Readers checking a previous Medro offer or an existing order. Medro’s public website and GLP-1 page returned not-found responses. Current enrollment and prices are unconfirmed.

The score above is a historical assessment of the earlier listing, not a recommendation for current treatment. Compare current provider information before choosing care.

Before you decide

The questions readers ask next after reading about Medro.

Closest here

Directory neighbors by retained score; a status assessment does not establish current prescription availability.

Weighing Medro against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Medro, and every provider that outranks it is listed on the Medro alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Medro's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

← Back to all rankings